Manipal Health Enterprises Limited made its stock market debut on Wednesday, August 5, 2026, with its shares listing at a 10.51% premium on the NSE. The stock opened at ₹652 on the NSE against its IPO issue price of ₹590 per share. On the BSE, the shares debuted at ₹655, representing an 11.02% premium over the issue price.

The ₹9,275.22 crore public issue was open for subscription from July 29 to July 31, 2026, and was subscribed 4.92 times by the end of the bidding period.

Manipal Health Enterprises IPO - Issue Details

Issue Type: Book Built Issue (Fresh Issue + OFS)
Total Issue Size: Up to ₹9,275.22 crore
Fresh Issue: Up to ₹8,000 crore
Offer for Sale (OFS): Up to ₹1,275.22 crore
Face Value: ₹2 per equity share
Price Band: ₹560 to ₹590 per share
Lot Size: 25 shares
Minimum Investment Amount (Retail Investor): ₹14,750 (25 shares at the upper price band)
Listing: BSE, NSE
Book Running Lead Managers: Kotak Mahindra Capital Company Limited, Axis Capital Limited, Goldman Sachs (India) Securities Private Limited, Jefferies India Private Limited, J.P. Morgan India Private Limited, UBS Securities India Private Limited and DBS Bank India Private Limited
Registrar: KFin Technologies Limited

Manipal Health Enterprises IPO Overall Subscription Status

[July 31, 2026, 7:00 PM]

Category	Subscription (x)
Qualified Institutional Buyers (QIBs)	8.25x
Non-Institutional Investors (NIIs)	1.02x
Retail Individual Investors (RIIs)	0.93x
Employees	2.19x
Total	4.92x

Utilisation of IPO Proceeds

The company intends to utilise the net proceeds from the fresh issue towards:

Repayment or prepayment, in full or in part, of certain outstanding borrowings and accrued interest thereon availed by one of its material subsidiaries, namely, Manipal Hospitals Private Limited
Acquisition of a minority stake in its stepdown subsidiary, Sahyadri Hospitals Private Limited
General corporate purposes.

About Manipal Health Enterprises Limited

Manipal Health Enterprises is among India's leading multispecialty hospital operators, managing a network of 49 hospitals with 13,037 licensed beds across 14 states and union territories as of March 31, 2026. Based on bed capacity, it is the country's largest private hospital network, while it ranks second in terms of the number of hospitals. During FY26, the company served approximately 7.63 million patients and had a medical workforce comprising 11,064 doctors.

The company provides advanced tertiary and quaternary care across key specialties, including cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and renal sciences (CONGO-R). These high-end specialties contributed 64.3% of its gross inpatient revenue in FY26. Over the years, Manipal Health has strengthened its presence through acquisitions such as AMRI Hospitals, Medica Synergie, and the Sahyadri Group. Looking ahead, the company plans to expand its healthcare infrastructure by adding around 2,426 licensed beds by 2030.

Key Financial Highlights

Particulars	FY26 (in ₹ crore)	FY25 (in ₹ crore)	FY24 (in ₹ crore)
Revenue from operations	10,335.75	8,242.25	6,171.63
EBITDA	2,795.94	2,247.07	1,776.60
Profit After Tax	916.52	1,081.67	533.20